American Journal of Public Health Research
ISSN (Print): 2327-669X ISSN (Online): 2327-6703 Website: Editor-in-chief: Apply for this position
Open Access
Journal Browser
American Journal of Public Health Research. 2015, 3(4A), 12-18
DOI: 10.12691/ajphr-3-4A-3
Open AccessResearch Article

Oral Zinc as Adjuvant Therapy for Pediatric Recurrent Pneumonia: A Prospective Study in a Tertiary Care Hospital

Tejesh Malla1, , Kalpana K Malla1, Brijesh Sathian2, Prithuja poudyal3, Eva Gauchan1 and Sahisnuta Basnet1

1Department of Pediatrics, Manipal College of Medical Sciences, Pokhara, Nepal

2Department of Community Medicine, Manipal College of Medical Sciences, Pokhara, Nepal`

3Department of Pediatrics, Kathmandu University Medical Sciences, Kathmandu, Nepal

Pub. Date: June 26, 2015
(This article belongs to the Special Issue Maternal and Child Health)

Cite this paper:
Tejesh Malla, Kalpana K Malla, Brijesh Sathian, Prithuja poudyal, Eva Gauchan and Sahisnuta Basnet. Oral Zinc as Adjuvant Therapy for Pediatric Recurrent Pneumonia: A Prospective Study in a Tertiary Care Hospital. American Journal of Public Health Research. 2015; 3(4A):12-18. doi: 10.12691/ajphr-3-4A-3


Zinc is an essential element required for the cell metabolism, including immunity. Therefore Zinc deficiency leads to susceptibility to infections and may affect pulmonary epithelial cell integrity. Many investigators have used zinc supplementation to see it’s effect on various diseases mainly diarrheal diseases and severe pneumonia. This study aims to evaluate the effect of oral Zinc supplementation in treatment and prevention of recurrent pneumonia. 506 Children aged 2 months to 60 months admitted during September 2011 to August 2014 for recurrent pneumonia with no other underlying illness in the Pediatric department of Manipal Teaching Hospital, Pokhara, Nepal were observed. Along with standard antibiotic treatment one group [Group I] received zinc (10 mg for < 6 months and 20 mg for ≥ 6 months for 10 days) and another group [Group II] did not receive Zinc. The primary outcome like resolution of tachypnea, chest in drawing, hypoxia, starting of oral feeds and hospital stay was noted. All cases were followed up every three monthly for one year to see the recurrence of pneumonia. Data was analyzed using SPSS version 16 and p < 0.01 was considered statistically significant. 20.24% of recurrent pneumonia meeting the inclusion criteria was evaluated. Maximum children (65.4%) were of age 2-12 months. Primary as well as secondary outcome was statistically significant (p<0.001) in Group I. The mean ± SD for primary outcome in Group I vs. Group II were –tachypnea (2.96±1.12 vs. 4.67 ± 1.61 days), chest in drawings (1.63 ±0.95 vs. 3.35 ±1.55 days), hypoxia (24.61 ±1.77 vs. 41.67 ± 2.11 hours), starting of oral feed (1.22 ±0.95 vs. 2.55 ± 1.23 days) and hospital stay (4.82 ±1.22 vs. 6.45 ± 1.99 days). In Group I 20/253 (7.9%) children lost follow up and 2/253(0.79%) patient died and in group II 1 (0.39%) died and 30 (11.85%) lost follow up. Recurrence of pneumonia was also significantly less (p<0.001) in zinc recipients. Determinants in two groups by logistic regression showed earlier resolution in zinc recipients with OR at 99% CI 9.654 (5.605, 16.625) for tachypnea, 14.506 (8.064, 26.095) for chest in drawings, 5.860 (3.415, 10.057) for hypoxia, 13.725 (7.270, 25.912) for starting oral feed and 0.075 (0.040, 0.140) for hospital stay. The recurrence of pneumonia was also less in group I with OR 3.348 at 99% CI (2.009, 5.581). Zinc as an adjuvant therapy is effective in treatment and prevention of recurrent pneumonia in children.

Adjuvant Therapy Zinc Pediatrics Recurrent Pneumonia

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  Bhutta ZA, Black RE, Brown KH, Gardner JM, Gore S,Hidayat A et al. Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: Pooled analysis of randomized controlled trials. Zinc Investigators’ Collaborative Group. Journal of Pediatrics 1999; 135 (6): 689-697.
[2]  Aggarwal R, Sentz J, Miller MA. Role of zinc administration in prevention of childhood diarrhea and respiratory illnesses: a meta-analysis. Pediatrics. 2007; 119 (6): 1120-1130.
[3]  Shakur MS et al. Serum and hair zinc in severely malnourished Bangladeshi children associated with or without acute lower respiratory infection. Indian Journal of Pediatrics. 2009; 76 (6): 609-614.
[4]  Wardlaw TM et al. Pneumonia: the forgotten killer of children. Geneva, World Health Organization, 2006.
[5]  Khaled S, Sherif AM, Kotb AM. Recurrent/Persistent Pneumonia among Children in Upper Egypt. Mediterr J Hematol Infect Dis. 2014; 6 (1): e2014024.
[6]  Owayed A, Campbell DM, Wang EEL. Underlying Causes of Recurrent Pneumonia in Children. Arch Pediatr Adolesc Med. 2000; 154 (2): 190-194.
[7]  Ozdemir O, Sari S, Bakirtas A, Zorlu P, Ertan U. Underlying diseases of recurrent pneumonia in Turkish children. Turk J Med Sci. 2010; 40 (1): 25-30.
[8]  WMA Declaration of Helsinki-Ethical Principles for Medical Research Involving Human Subjects [Internet]. 2013. Available from:
[9]  Wald E. Recurrent and non-resolving pneumonia in children. Semin Respir Infect. 1993; 846-58.
[10]  World Health Organization: Acute respiratory infections in children. Case management in small hospitals in developing countries 1990, Geneva: WHO/ARI/90.5990.
[11]  World Health Organization Pneumonia Vaccine Trial Investigator’s Group. Standardization of Interpretation of Chest Radiographs for the Diagnosis of Pneumoniain Children. WHO/ V&B/ 01.35. Geneva, Switzerland: World Health Organization; 2001.
[12]  World Health Organization. Pocket Book of Hospital Care for Children: Guidelines for the Management of Common Illnesses With Limited Resources. Geneva, Switzerland: World Health Organization; 2005.
[13]  GhaiOP, GuptaP, PaulVK. Ghai Essential Pediatrics: Nutrition and macronutrient disorders In 6th ed. 2008; 93-118.
[14]  Basnet S, Shrestha PS, Sharma A, Mathisen M, Prasai R, Bhandari N et al. A Randomized Controlled Trial of Zinc as Adjuvant Therapy for Severe Pneumonia in Young Children. PEDIATRICS. 2012; 129 (4): 701-708.
[15]  World Health Organization and United Nations Children Fund. Clinical management of acute diarrhoea. WHO/UNICEF Joint Statement, August, 2004.
[16]  Brooks WA, Yunus M, Santosham M, Wahed MA, Nahar K, Yeasmin S, Black RE. Zinc for severe pneumonia in very young children: double-blind placebo-controlled trial. Lancet. 2004; 363 (9422): 1683-8.
[17]  Mahalanabis D, Lahiri M, Paul D, Gupta S, Gupta A, Wahed MA, Khaled MA. Randomized, double-blind, placebo-controlled clinical trial of the efficacy of treatment with zinc or vitamin A in infants and young children with severe acute lower respiratory infection. Am J ClinNutr. 2004; 79 (3): 430-6.
[18]  Bose A, Coles CL, Gunavathi, John H, Moses P, Raghupathy P, Kirubakaran C, Black RE, Brooks WA, Santosham M. Efficacy of zinc in the treatment of severe pneumonia in hospitalized children <2 y old. Am J ClinNutr. 2006; 83 (5): 1089-96.
[19]  Shah GS, Dutta AK, Shah D, MishraOP. Role of zinc in severe neumonia: a randomized double bind placebo controlled study. Italian Journal of Pediatrics 2012; 38: 36
[20]  Puumalainen T, Quiambao B, Abucejo-Ladesma E, et al; ARIVAC Research Consortium. Clinical case review: a method to improve identification of true clinical and radiographic pneumonia in children meeting the World Health Organization definition for pneumonia. BMC Infect Dis. 2008; 8: 95.
[21]  Shankar AH, Prasad AS. Zinc and immune function: the biological basis of altered resistance to infection. Am J ClinNutr 1998; 68: 447S-63S.
[22]  Wintergerst ES, Maggini S, Hornig DH. Contribution of selected vitamins and trace elements to immune function. Ann NutrMetab 2007; 51: 301-23.
[23]  Bahl R, Bhandari N, Hambidge KM, Bhan MK. Plasma zinc as a predictor of diarrheal and respiratory morbidity in children in an urban slum setting. Am J ClinNutr 1998; 68 (2 Suppl): 414S-7S.
[24]  Black RE. Zinc deficiency, infectious disease and mortality in the developing world. J Nutr 2003; 133: 1485S-9S.
[25]  Valavi E, Hakimzadeh M, Shamsizadeh A, Aminzadeh M, Alghasi A. The Efficacy of Zinc Supplementation on Outcome of Children with Severe Pneumonia.A Randomized Double-blind Placebo-controlled Clinical Trial. The Indian Journal of Pediatrics. 2011; 78 (9); 1079-1084.
[26]  Bansal A, Parmar VR, Basu S, Kaur J, Jain S,Saha A,Chawla D. Zinc Supplementation in Severe Acute Lower Respiratory Tract Infection in Children: A Triple-Blind Randomized Placebo Controlled Trial.The Indian Journal of Pediatrics. 2011; 78 (1): 33-37.
[27]  Lassi ZS, Haider BA, Bhutta ZA. Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months. Cochrane Database of Systematic Reviews 2010; (12): CD005978.